Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer: A Retrospective Study

The treatment efficacy of advanced breast cancer is still not promising. This study aimed to compare the efficacy and safety of docetaxel/S-1 (DS1) versus docetaxel/capecitabine (DX) as the first-line treatment for advanced breast cancer. From June 2008 to June 2013, 22 patients with advanced breast...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Li, Jinyu, You, Junhao, Si, Wen, Zhu, Yanyun, Chen, Yi, Yang, Bo, Han, Chun, Linghu, Ruixia, Zhang, Xingyang, Jiao, Shunchang, Yang, Junlan
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2015
Matèries:
5700
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616799/
https://ncbi.nlm.nih.gov/pubmed/26469889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001340
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars